Family facts
IDVParent PIID36F79721D0166
Also listed as36F797-21-D-0166
Agency260-Network Contract Office 20 (36C260)
Awarding office260-Network Contract Office 20 (36C260)
Awarding agencyDepartment of Veterans Affairs (VA)
Period endSep 30, 2026
IDV obligated$16.8M
Child awards11
Places of performance
StatesMO, NC, OR
Distinctive task orders
1175A50324F80012 — PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))
Biocryst Pharmaceuticals, Inc. · $13.9M · PoP Sep 29, 2025
36C26025F0070 — BULK ORLADEYO PHARMACEUTICAL
Biocryst Pharmaceuticals, Inc. · $395K · PoP Mar 11, 2026
36C26024F0270 — BULK ORDER ORLADEYO
Biocryst Pharmaceuticals, Inc. · $388K · PoP Mar 11, 2025
36C26025F0296 — BULK ORDER ORLADEYO FOR VETERAN CARE.
Biocryst Pharmaceuticals, Inc. · $382K · PoP Sep 8, 2026
36C26025F0024 — BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).
Biocryst Pharmaceuticals, Inc. · $380K · PoP Sep 30, 2025
36C26024F0625 — BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP
Biocryst Pharmaceuticals, Inc. · $379K · PoP Sep 8, 2025
36C26022F0215 — BEROTRALSTAT HCL 150MG CAP,ORAL BULK, 72769-0101-01
Biocryst Pharmaceuticals, Inc. · $369K · PoP May 31, 2023
36C26026F0006 — PHARM - ORLADEYO
Biocryst Pharmaceuticals, Inc. · $360K · PoP Sep 30, 2026
36C26023F0144 — BEROTRALSTAT
Biocryst Pharmaceuticals, Inc. · $340K · PoP Jan 19, 2024
36C26024F0258 — ORLADEYO 150MG CAPS
Biocryst Pharmaceuticals, Inc. · $202K · PoP Oct 4, 2024
36C26026F0294 — ORLADEYO 150MG CAP
Biocryst Pharmaceuticals, Inc. · $151K · PoP Sep 30, 2026
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly